(EMAILWIRE.COM, April 29, 2022 ) The Artificial Saliva Market is expected to be worth US$ 1.5 billion by the year 2017-2025, at a CAGR of 13.9% between 2017-2025. Digital health is into occupation of a noteworthy position in our lives, thereby rendering it a significant tool in the medical device trends going forward. This would be the overall outlook of the healthcare vertical in the forecast period.
The WHO says that oral diseases are the fourth-most expensive disease to treat across the world. Therefore, oral health maintenance expenditure is a huge healthcare concern impacting both developed and developing countries. The artificial saliva market is projected to grow with an exponential CAGR of 13.9% from 2017-2025 and be valued at just under US$ 1.5 billion by then.
Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/16891
Company Profiles:
GlaxoSmithKline plc
Cipla Limited
Mission Pharmacal Company
Fresenius Kabi
Parnell Pharmaceuticals, Inc.
CCMed Group
Entod International
Midatech Pharma Plc.
Forward Science
Valeant Pharmaceuticals International, Inc.
Biocosmetics Laboratories
Icpa Health Products LTD.
Perrigo
Laboratorios Kin, S.A.
Request for Methodology@ https://www.persistencemarketresearch.com/methodology/16891
Product Type Oral Sprays Rehydration Preferred Option in Artificial Saliva Market
Oral sprays account for a market share of almost 30% of the artificial saliva market by product type in 2017 and are anticipated to grow to 31% by end of 2025. Oral sprays have an attractiveness index of 1.6, more than all other product types in the artificial saliva market. Oral sprays are desired because of their affordability along with the immense convenience offered.
Age Group Pediatric Patients Rarely Turn to the Artificial Saliva Market
Adult patients dominate the artificial saliva market by age group and this is unlikely to change anytime soon as the dry mouth condition is typically more common in adult patients than pediatric ones. The adult segment is projected to record a massive CAGR of 14.2% for the period 2017-2025.
Distribution Channel Compel Retail Pharmacies to Stock up in Artificial Saliva Market
Retail pharmacies hold the key to effective distribution channel strategies in the artificial saliva market. Patients tend to visit retail pharmacies more than either hospital pharmacies or mail order pharmacies for a number of reasons mentioned in the report.
Retail pharmacies are assessed to have a value of more than US$ 200 million in 2017 alone, making it imperative for key stakeholders in the artificial saliva market to target this distribution channel.
Access Full Report@ https://www.persistencemarketresearch.com/checkout/16891
Region Spitting Distance between North America and Europe in Artificial Saliva Market
North America and Europe have a similar market share in the artificial saliva market with the former being slightly larger and on track to witness a higher CAGR.
The North America artificial saliva market is expected to push past US$ 535 million by the end of the forecast period because of the easy availability of artificial saliva products and the presence of a large consumer base on the continent coupled with a strong medical infrastructure.
Important Insights on the Artificial Saliva Market
Companies are advised to focus their attention on brand-building exercises as the artificial saliva market is awash with options and customers tend to gravitate to known brands for loyalty and trust factors. Brand development helps create an emotional attachment with the end-user and thus, companies in the artificial saliva market should take this very seriously indeed.
In addition to this, a robust distribution network is essential for increasing both the organizational top and bottom lines. Promotional activities held in tandem with oncologists, physicians, and retail pharmacies are the perfect opportunity to boost sales in the artificial saliva market. Bridging the demand-supply imbalance can go a long way in the artificial saliva market.
For e.g. Laboratories Kin S.A. has an extremely profitable business in Brazil because of its pharmacist network and hospitals in the country as opposed to its offerings outside the nation.
Related Reports:
In Vitro Protein Expression Market – Global in-vitro protein expression market has shown growth at a value CAGR of 6.0% throughout forecast to reflect a market value more than US$ 250 Mn by 2025 end.
North America Synthetic Opioids Market – Globally, semi-synthetic opioids segment accounted for more than 90% revenue share of the industry in 2016 and is expected to gain more than 10 BPS in its market share by 2024.
About Us: Persistence Market Research
Discussion about this post